Validation of a treatment satisfaction questionnaire in non-Hodgkin lymphoma: assessing the change from intravenous to subcutaneous administration of rituximab

BACKGROUND: A subcutaneous (SC) formulation of rituximab (MabThera(®)/Rituxan(®)) has been developed that could reduce administration time and improve patient satisfaction with treatment. The Rituximab Administration Satisfaction Questionnaire (RASQ) was created to assess patients’ perceptions and s...

Descripción completa

Detalles Bibliográficos
Autores principales: Theodore-Oklota, Christina, Humphrey, Louise, Wiesner, Christof, Schnetzler, Gabriel, Hudgens, Stacie, Campbell, Alicyn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028167/
https://www.ncbi.nlm.nih.gov/pubmed/27695295
http://dx.doi.org/10.2147/PPA.S108489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028167/
https://www.ncbi.nlm.nih.gov/pubmed/27695295
http://dx.doi.org/10.2147/PPA.S108489

Ejemplares similares